FDA — authorised 28 April 2020
- Application: NDA210296
- Marketing authorisation holder: BANNER LIFE SCIENCES
- Local brand name: BAFIERTAM
- Indication: CAPSULE, DELAYED RELEASE — ORAL
- Status: approved
🇺🇸 Bafiertam in United States
FDA authorised Bafiertam on 28 April 2020
Marketing authorisation
Other Other approved in United States
Frequently asked questions
Is Bafiertam approved in United States?
Yes. FDA authorised it on 28 April 2020.
Who is the marketing authorisation holder for Bafiertam in United States?
BANNER LIFE SCIENCES holds the US marketing authorisation.